Nautilus Biotechnology Inc (NAUT)
2.65
+0.08
(+3.11%)
USD |
NASDAQ |
Nov 05, 16:00
2.65
0.00 (0.00%)
After-Hours: 16:18
Nautilus Biotechnology Total Assets (Quarterly): 259.70M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 259.70M |
| June 30, 2024 | 272.75M |
| March 31, 2024 | 288.65M |
| December 31, 2023 | 305.56M |
| September 30, 2023 | 318.34M |
| June 30, 2023 | 330.77M |
| March 31, 2023 | 345.88M |
| December 31, 2022 | 350.05M |
| Date | Value |
|---|---|
| September 30, 2022 | 359.31M |
| June 30, 2022 | 371.71M |
| March 31, 2022 | 384.67M |
| December 31, 2021 | 398.45M |
| September 30, 2021 | 385.35M |
| June 30, 2021 | 393.28M |
| December 31, 2020 | 85.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.01M
Minimum
Dec 2020
398.45M
Maximum
Dec 2021
323.30M
Average
345.88M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Incyte Corp | 5.012B |
| Merck & Co Inc | 112.63B |
| Neogen Corp | 4.503B |
| Pfizer Inc | 216.19B |
| Repligen Corp | 2.862B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.27M |
| Shareholders Equity (Quarterly) | 223.43M |